ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 41 filers reported holding ENZO BIOCHEM INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $350,503 | -23.9% | 250,359 | 0.0% | 0.02% | -20.7% |
| Q2 2023 | $460,661 | -24.3% | 250,359 | 0.0% | 0.03% | -34.1% |
| Q1 2023 | $608,372 | +69.5% | 250,359 | 0.0% | 0.04% | +63.0% |
| Q4 2022 | $359,000 | -35.8% | 250,359 | 0.0% | 0.03% | -42.6% |
| Q3 2022 | $559,000 | -13.1% | 250,359 | 0.0% | 0.05% | +4.4% |
| Q2 2022 | $643,000 | -11.9% | 250,359 | 0.0% | 0.04% | -4.3% |
| Q1 2022 | $730,000 | -9.2% | 250,359 | 0.0% | 0.05% | -4.1% |
| Q4 2021 | $804,000 | -9.3% | 250,359 | 0.0% | 0.05% | 0.0% |
| Q3 2021 | $886,000 | +5.9% | 250,359 | -5.1% | 0.05% | +4.3% |
| Q2 2021 | $837,000 | – | 263,912 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
| VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
| AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
| Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
| Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
| Corsair Capital Management | 58,657 | $188,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |